Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Cash from Operations (2020 - 2025)

Rapid Micro Biosystems (RPID) has disclosed Cash from Operations for 6 consecutive years, with 3246000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Operations rose 67.24% to 3246000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 31062000.0 through Dec 2025, up 29.65% year-over-year, with the annual reading at 31062000.0 for FY2025, 29.65% up from the prior year.
  • Cash from Operations hit 3246000.0 in Q4 2025 for Rapid Micro Biosystems, up from 9051000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 3246000.0 in Q4 2025 to a low of 19309000.0 in Q3 2021.
  • Historically, Cash from Operations has averaged 11690350.0 across 5 years, with a median of 10690500.0 in 2021.
  • Biggest five-year swings in Cash from Operations: crashed 149.22% in 2021 and later surged 67.24% in 2025.
  • Year by year, Cash from Operations stood at 12887000.0 in 2021, then increased by 9.56% to 11655000.0 in 2022, then increased by 18.52% to 9497000.0 in 2023, then dropped by 4.34% to 9909000.0 in 2024, then soared by 67.24% to 3246000.0 in 2025.
  • Business Quant data shows Cash from Operations for RPID at 3246000.0 in Q4 2025, 9051000.0 in Q3 2025, and 9700000.0 in Q2 2025.